title: Aminaphtone in idiopathic cyclic oedema syndrome.
abstract: OBJECTIVE
  Idiopathic cyclic oedema syndrome is a group of clinical conditions that exhibit a vascular capillary hyperpermeability accompanied by oedema caused by the interstitial retention of fluid. The objective of the current study was to evaluate the efficacy of aminaphtone in the treatment of idiopathic cyclic oedema.
  
  
  METHODS
  A total of 15 female patients with clinical diagnosis of idiopathic cyclic oedema and aged between 22 and 49 years and a mean of 37.7 years were evaluated. After diagnosis, the patients were submitted to lower limb volumetry and asked to record the weight in the morning and evening at fixed times. One tablet of aminaphtone was prescribed every 8 h and on the fifth day the patients were reassessed. Percentages and the paired t-test were utilized for statistical analysis, with an alpha error of 5% considered acceptable (P value <0.05).
  
  
  RESULTS
  A significant reduction in limb size was detected after treatment using aminaphtone (P value <0.0001) with losses between 9 g and 370 g, and an average loss of 116.9 g. Variations in weights in the morning and evening were significant (P value <0.00001) with a maximum difference of 3 kg and a minimum of 120 g. Improvements were reported for 70% of patients.
  
  
  CONCLUSIONS
  Aminaphtone is efficacious in the reduction of oedema in patients with idiopathic cyclic oedema.
authors.affiliation: Medical School in São José do Rio Preto (FAMERP), São José do Rio Preto-Sao Paulo, CEP 15020-010, Brazil. godoyjmp@riopreto.com.br
authors.forename: J M
authors.initials: JM
authors.lastname: Pereira de Godoy
mesh_terms: D010129:4-Aminobenzoic Acid / Q000008:administration & dosage; D000328:Adult; D001835:Body Weight; D002199:Capillary Permeability; D002940:Circadian Rhythm; D004487:Edema / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D045604:Extracellular Fluid / Q000378:metabolism; D005260:Female; D006801:Humans; D007866:Leg; D008875:Middle Aged; D013577:Syndrome; D016896:Treatment Outcome; D062366:para-Aminobenzoates
chemical_list: D062366:para-Aminobenzoates; C016217:aminaftone; D010129:4-Aminobenzoic Acid